Wespac Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Wespac Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$338.18 - $362.46 $226,580 - $242,848	670 New	670 $232,000
Q2 2019 Jul 23, 2019	SELL	$164.61 - $190.37 $553,254 - $639,833	-3,361 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$163.73 - $194.7 $550,296 - $654,386	3,361 New	3,361 $618,000
Q4 2018 Jan 31, 2019	SELL	$151.91 - $192.21 $200,369 - $253,524	-1,319 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$167.73 - $192.74 $221,235 - $254,224	1,319 New	1,319 $254,000
Q2 2018 Aug 08, 2018	SELL	$145.72 - $169.96 $775,376 - $904,357	-5,321 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$151.6 - $177.13 $806,663 - $942,508	5,321 New	5,321 $867,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.